Vyndamax 61 MG capsule UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FP9BM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,185
Award facts
- Contract value 100% obligated
- $29,185.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $29,185.16 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsules in unit dose packaging of 30 units. The contract, awarded on January 30, 2026, with an ultimate completion date of February 23, 2026, utilizes firm fixed-price pricing and carries no set-aside designation, indicating competitive award. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's parent company Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2031.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military healthcare procurement, regularly supplying medications across multiple therapeutic domains to military treatment facilities and veteran healthcare programs. Vyndamax (tafamidis) is a specialty pharmaceutical used in the treatment of transthyretin amyloidosis, reflecting the Defense Logistics Agency's responsibility for ensuring adequate supply of both common and specialized medications to support the Department of Defense healthcare mission. The company's competitive award history and comprehensive pharmaceutical portfolio demonstrate its capability to meet federal procurement requirements for complex medical supply needs on an expedited basis.
Quick answers
Who was awarded contract SPE2DR26FP9BM?
SPE2DR26FP9BM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FP9BM worth?
The government has obligated $29,185 on SPE2DR26FP9BM.
Is contract SPE2DR26FP9BM an order under another contract?
Yes. SPE2DR26FP9BM is a delivery order under SPE2DR25D3005, an indefinite delivery contract.
Was contract SPE2DR26FP9BM competed?
The extent of competition for SPE2DR26FP9BM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award